跳至主要内容
临床试验/NCT00892268
NCT00892268终止2 期

Acupuncture for the Treatment of Aromatase Inhibitor Associated Joint Pain in Post-Menopausal Breast Cancer Patients

University of Arizona0 个研究点目标入组 68 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
2 期
状态
终止
入组人数
68
主要终点
Improvement in pain, as defined by the WOMAC global score at 6 weeks

研究概览

简要总结

RATIONALE: Acupuncture may reduce joint pain in postmenopausal women with breast cancer. It is not yet known whether acupuncture is more effective than standard therapy analgesics in decreasing joint pain caused by aromatase inhibitors.

PURPOSE: This randomized phase II trial is studying acupuncture to see how well it works compared with medication in reducing pain in postmenopausal women with breast cancer and joint pain.

详细描述

OBJECTIVES:

Primary

  • To evaluate the efficacy of acupuncture in reducing pain, defined by improvements in overall WOMAC score at 6 weeks, in post-menopausal women with breast cancer and aromatase inhibitor (AI)-associated arthralgia.

Secondary

  • To identify biologic correlates to acupuncture efficacy in this specific syndrome of AI-associated pain.
  • To evaluate the efficacy of acupuncture in these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Improvement in pain, as defined by the WOMAC global score at 6 weeks

次要结局

  • Acupuncture efficacy as defined by bio-correlates, e.g., changes in BDNF and STGP levels
  • Menopausal symptoms as defined by the FACT-ES

研究者

申办方类型
Other

相似试验